newsfilter
← Latest News
GlobeNewswire·

Neuronetics Announces Proposed Public Offering of Common Stock

STIM
  • Neuronetics, Inc. (NASDAQ: STIM) has commenced an underwritten public offering of its common stock, with all shares sold by the company.
  • Neuronetics intends to grant underwriters a 30-day option to purchase up to an additional 15% of the offered shares at the public offering price less the underwriting discount.
  • William Blair serves as the lead bookrunning manager, while BTIG and Canaccord Genuity act as additional bookrunners for the offering.
  • The offering is subject to market conditions, with no assurance provided regarding completion, actual size, or final terms.
  • On November 5, 2026, the company entered into Amendment No. 6 to its credit agreement with Perceptive Credit Holdings IV, LP to reduce certain revenue covenants.
  • Satisfaction of conditions precedent for the Perceptive Sixth Amendment includes a prepayment of no less than $15,000,000 plus accrued interest, fees, and expenses.
  • If the conditions for the Perceptive Amendment are not met or waived by November 30, 2026, the amendment will automatically terminate.
  • The company anticipates that satisfying the amendment conditions will resolve the going concern risk referenced in recent Form 10-Q filings.
  • The shares are offered pursuant to a shelf registration statement on Form S-3 filed with the SEC on July 3, 2025, and declared effective on July 18, 2025.
  • Final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC.
  • Neuronetics operates as a leader in interventional mental health through its NeuroStar® TMS technology & the Greenbrook network of interventional psychiatry clinics.
Company
Neuronetics
Keywords
Nasdaq:STIM, Neuronetics